Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Regal Rexnord Q1 EPS $2.68 Beats $2.41 Estimate

Regal Rexnord (NYSE:RRX) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.41 by 11.2 percent.

byBenzinga Newsdesk

April 27, 2022

1 minute read

Regal Rexnord (NYSE:RRX) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.41 by 11.2 percent.

Applied Molecular’s Ulcerative Colitis Candidate Fails To Separate From Placebo In Untreated Patients

By Vandana Singh

Today, 9:04 AM

Applied Molecular Transport Inc (NASDAQ:AMTI) announced topline Phase 2 results from the LOMBARD monotherapy trial for AMT-101 in biologic-naïve and experienced…

AMTI

Wells Fargo Maintains Equal-Weight on Microchip Technology, Raises Price Target to $85

By Benzinga Newsdesk

Today, 9:04 AM

Wells Fargo analyst Gary Mobley maintains Microchip Technology (NASDAQ:MCHP) with a Equal-Weight and raises the price target from $80 to $85.

MCHP

Piper Sandler Bumps Up Tesla Price Target By 4%

By Anusuya Lahiri

Today, 9:04 AM

Piper Sandler analyst Alexander Potter raised the price target on Tesla Inc (NASDAQ:TSLA) to $1,350 from $1,300 and reiterated an Overweight rating on…

TSLA

EU Initiates Antitrust Inquiry Against Google’s Advertising Technology

By Anusuya Lahiri

Today, 9:04 AM

Brussels has launched a formal antitrust probe against Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google to explore a possible breach of the…

GOOG

Regal Rexnord Q1 EPS $2.68 Beats $2.41 Estimate

Related Posts

Applied Molecular’s Ulcerative Colitis Candidate Fails To Separate From Placebo In Untreated Patients

Wells Fargo Maintains Equal-Weight on Microchip Technology, Raises Price Target to $85

Piper Sandler Bumps Up Tesla Price Target By 4%

EU Initiates Antitrust Inquiry Against Google’s Advertising Technology